Salarius Pharmaceuticals
$0.68079876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.6807
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.0313 (+4.82%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell SLRX and other stocks, options, ETFs, and crypto commission-free!
About SLRX
Salarius Pharmaceuticals, Inc. Common Stock, also called Salarius Pharmaceuticals, is a clinical-stage oncology company. Read More The firm focuses on the development of Salarius' clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company was founded in 2014 and is headquartered in Houston, TX.
Employees
8
Headquarters
Houston, Texas
Founded
2014
Market Cap
9.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
127.76K
High Today
$0.70
Low Today
$0.6495
Open Price
$0.65
Volume
57.57K
52 Week High
$24.45
52 Week Low
$0.5552
Collections
SLRX Earnings
-$0.73
-$0.49
-$0.24
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 29, Pre-Market